SEC 13F Intelligence

Abg-Wtt Global Life Science Capital Partners GP Ltd / LUNG

Abg-Wtt Global Life Science Capital Partners GP Ltd’s Pulmonx Corp Position

Does Abg-Wtt Global Life Science Capital Partners GP Ltd own Pulmonx Corp (LUNG)? Not currently — the last reported position was 60.2K shares worth $405,173 in Q1 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$405,173
Q1 2025
Shares
60.2K
% of Portfolio
+1.06%
Quarters Held
18
position exited

Position History LUNG

Reported value by quarter
Q4 ’20: $56MQ4 ’20Q1 ’21: $37MQ2 ’21: $4MQ3 ’21: $3MQ3 ’21Q4 ’21: $2MQ1 ’22: $1MQ2 ’22: $886,000Q2 ’22Q3 ’22: $1MQ4 ’22: $507,520Q1 ’23: $673,081Q1 ’23Q2 ’23: $789,274Q3 ’23: $621,907Q4 ’23: $767,601Q4 ’23Q1 ’24: $558,091Q2 ’24: $381,693Q3 ’24: $499,091Q3 ’24Q4 ’24: $408,785Q1 ’25: $405,173filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202560.2K$405,173+1.06%
Q4 202460.2K$408,785+0.94%
Q3 202460.2K$499,091+2.48%
Q2 202460.2K$381,693+1.27%
Q1 202460.2K$558,091+1.34%
Q4 202360.2K$767,601+1.50%
Q3 202360.2K$621,907+2.98%
Q2 202360.2K$789,274+14.32%
Q1 202360.2K$673,081+10.62%
Q4 202260.2K$507,520+8.20%
Q3 202260.2K$1M+6.26%
Q2 202260.2K$886,000+3.13%
Q1 202260.2K$1M+12.13%
Q4 202160.2K$2M+26.20%
Q3 202193.8K$3M+22.93%
Q2 202193.8K$4M+8.00%
Q1 2021815.0K$37M+40.66%
Q4 2020815.0K$56M+49.03%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Abg-Wtt Global Life Science Capital Partners GP Ltd’s full portfolio or all institutional holders of LUNG.